- Home
- ABUS vs RC Comparison
ABUS vs RC Comparison
Compare ABUS & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- RC
- Stock Information
- Founded
- ABUS 2005
- RC 2007
- Country
- ABUS United States
- RC United States
- Employees
- ABUS N/A
- RC N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- RC Real Estate Investment Trusts
- Sector
- ABUS Health Care
- RC Real Estate
- Exchange
- ABUS Nasdaq
- RC Nasdaq
- Market Cap
- ABUS 670.3M
- RC 765.0M
- IPO Year
- ABUS N/A
- RC N/A
- Fundamental
- Price
- ABUS $3.43
- RC $4.43
- Analyst Decision
- ABUS Strong Buy
- RC Hold
- Analyst Count
- ABUS 4
- RC 7
- Target Price
- ABUS $5.50
- RC $7.46
- AVG Volume (30 Days)
- ABUS 610.0K
- RC 1.8M
- Earning Date
- ABUS 07-31-2025
- RC 08-06-2025
- Dividend Yield
- ABUS N/A
- RC 11.25%
- EPS Growth
- ABUS N/A
- RC N/A
- EPS
- ABUS N/A
- RC N/A
- Revenue
- ABUS $6,403,000.00
- RC N/A
- Revenue This Year
- ABUS $3.35
- RC N/A
- Revenue Next Year
- ABUS N/A
- RC $33.07
- P/E Ratio
- ABUS N/A
- RC N/A
- Revenue Growth
- ABUS N/A
- RC N/A
- 52 Week Low
- ABUS $2.71
- RC $3.93
- 52 Week High
- ABUS $4.73
- RC $9.54
- Technical
- Relative Strength Index (RSI)
- ABUS 50.84
- RC 51.29
- Support Level
- ABUS $3.46
- RC $4.31
- Resistance Level
- ABUS $3.65
- RC $4.59
- Average True Range (ATR)
- ABUS 0.12
- RC 0.14
- MACD
- ABUS -0.00
- RC 0.02
- Stochastic Oscillator
- ABUS 35.29
- RC 63.04
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.